id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1978-N-0995-0001,FDA,FDA-1978-N-0995,Regulatory Analysis for Proposed Rulemaking to Delete Labeling Requirements for Patient Labeling for Estrogenic Drug Products,Supporting & Related Material,Regulatory Analysis,2014-09-23T04:00:00Z,2014,9,,,2014-09-23T14:23:08Z,,0,0,0900006480591668
FDA-1978-N-0995-0006,FDA,FDA-1978-N-0995,Withdrawal of Certain Pre-1986 Proposed Rules: Opportunity for Public Comment,Notice,Notice of Intent,2014-09-23T04:00:00Z,2014,9,2014-09-23T04:00:00Z,1991-10-29T04:59:59Z,2014-09-23T14:32:41Z,,0,0,0900006480591684
FDA-1978-N-0995-0002,FDA,FDA-1978-N-0995,Estrogens to Treat Postpartum Breast Engorgement; Proposed Requirements for Patient Labeling,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2014-09-23T04:00:00Z,2014,9,2014-09-23T04:00:00Z,1979-01-05T04:59:59Z,2014-09-23T14:25:56Z,,0,0,0900006480591673
FDA-1978-N-0995-0007,FDA,FDA-1978-N-0995,Withdrawal of Proposed Rules,Notice,Withdrawal,2014-09-23T04:00:00Z,2014,9,2014-09-23T04:00:00Z,,2014-09-23T14:41:26Z,,0,0,0900006480591686